Evaluating Lebrikizumab in Pigmented Skin

Name: Evaluating Lebrikizumab in Pigmented Skin
Uploaded: 2025-07-16T04:00:00+00:00
Duration: 4 min 23 s
Description: Andrew Alexis, MD, MPH, discusses new data presented at the Revolutionizing Atopic Dermatitis (RAD) Conference from the phase 3b Admirable trial, the first

Home
Videos
Updates in Atopic Dermatitis

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Clinical Data on Switching to Upadacitinib
Clinical Data on Switching to Upadacitinib
Updates in Atopic Dermatitis
Clinical Data on Switching to Upadacitinib
Christopher Bunick, MD, PhD, FAAD
Christopher Bunick, MD, PhD, FAAD
Anti-OX40 Ligand Antibody Trials
Anti-OX40 Ligand Antibody Trials
Updates in Atopic Dermatitis
Anti-OX40 Ligand Antibody Trials
Stephan Weidinger, MD, PhD
Stephan Weidinger, MD, PhD
Chronic Hand Eczema
Chronic Hand Eczema
Updates in Atopic Dermatitis
Chronic Hand Eczema
Raj Chovatiya, MD, PhD, MSCI, FAAD
Raj Chovatiya, MD, PhD, MSCI, FAAD
Understanding Disparities in AD
Understanding Disparities in AD
Updates in Atopic Dermatitis
Understanding Disparities in AD
Raj Chovatiya, MD, PhD, MSCI, FAAD
Raj Chovatiya, MD, PhD, MSCI, FAAD

VIDEOS

PODCASTS

COLUMNS

DERMWIRE NEWS

CONFERENCE COVERAGE

DERMATOLOGY HUB

Evaluating Lebrikizumab in Pigmented Skin

Recommended

Evaluating Lebrikizumab in Pigmented Skin

Recommended

Title